Search for: "Boehringer Ingelheim Pharmaceutical, Inc" Results 21 - 40 of 90
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Aug 2016, 1:05 pm by jromDLT
You may be entitled to compensation for your medical bills, lost wages, pain and suffering and other damages that can be pursued in a defective drug lawsuit against the manufacturer of Pradaxa, Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
5 Aug 2016, 2:10 pm by Tom Lamb
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention   (Posted by Tom Lamb at DrugInjuryWatch.com)   This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors… [read post]
13 Jul 2016, 1:56 pm by Tom Lamb
About a month later, however, only those three diabetes drugs from Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
8 May 2016, 9:59 pm by Patent Docs
KG; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
8 Jul 2015, 8:31 am by Katharyn Grant (US)
Labs., Inc., 625 F.2d 1055 (3d Cir. 1980) (holding unique coloring of prescription drug capsule constituted protectable trade dress); Boehringer Ingelheim G.m.b.H. v. [read post]
9 Mar 2015, 2:38 pm by The Public Employment Law Press
Litigation and Government Investigations at Boehringer Ingelheim Pharmaceuticals where she oversaw all U.S. litigation and government investigations. [read post]
5 Jun 2014, 7:06 am by Daniel Schwartz
 Boehringer Ingelheim Pharmaceuticals, Inc., which was decided just a few months before I started my career in employment law. [read post]
3 Jun 2014, 4:41 pm
That same year, Boehringer Ingelheim Pharmaceuticals, Inc. made $1.5 billion in sales of Pradaxa. [read post]
24 Apr 2014, 8:34 am by AmericanConferenceInstitute
Companies confirmed to speak to date include: Asuragen ■ Amgen ■ Avanir Pharmaceuticals ■ Bayer ■ Biocryst Pharmaceuticals ■ Biogen Idec ■ Blueprint Medicines ■ Covidien ■ Edwards Lifesciences ■ Eisai Inc ■ Endo Pharmaceuticals ■ Ipsen… [read post]
3 Apr 2014, 5:00 am
Jan. 30, 2014) (“Actos”); In re Ethicon, Inc. [read post]
13 Feb 2014, 6:00 am by LTA-Editor
District Court Judge David Herndon from the Southern District of Illinois imposed close to $1 million in punitive damages on defendants Boehringer Ingelheim International GMBH (“BII”) and Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
28 Jan 2014, 11:53 am
  In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., and Boehringer Ingelheim Int’l. [read post]
25 Jan 2014, 9:43 am by Barry Barnett
In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., No. 13-3898 (7th Cir. [read post]
15 Jan 2014, 5:43 am by Robert Kreisman
Herndon of the Southern District of Illinois has ordered that Boehringer Ingelheim Pharmaceuticals, Inc. [read post]